Literature DB >> 25610117

Cerebral Venous Thrombosis and Pulmonary Embolism with Prothrombin G20210A Gene Mutation.

Canan Eren Dagli1, Nurhan Koksal1, Selma Guler2, Mehmet Emin Gelen1, Nurhan Atilla1, Deniz Tuncel3.   

Abstract

A 25-year-old man presented with symptoms of syncope, cough, headache and hemoptysis. Cranial MR and venography showed thrombus formation in the right transverse sinus and superior sagittal sinus. Computed tomographic pulmonary angiography (CTPA) showed an embolic thrombus in the right pulmonary truncus and lung abscess. The patient was young, and there were no signs of lower extremity deep venous thrombosis or other major risk factors for pulmonary embolism (PE) including cardiac anomaly. The only risk factor we were able to identify was the presence of the prothrombin G20210A gene mutation. Anticoagulant treatment with oral warfarin (10 mg daily) and imipenem (4X500 mg) was started. The patient was hospitalized for antibiotic and anticoagulation therapies for three weeks and was discharged on lifelong treatment with warfarin (5 mg daily).

Entities:  

Keywords:  Prothrombin G20210A gene mutation; cerebral venous thrombosis; pulmonary embolism

Year:  2010        PMID: 25610117      PMCID: PMC4261312          DOI: 10.5152/eajm.2010.11

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  6 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Pulmonary embolism: an unusual complication of cerebral venous thrombosis.

Authors:  S Cakmak; N Nighoghossian; V Desestret; M Hermier; S Cartalat-Carel; L Derex; J Honnorat; P Trouillas
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

3.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

4.  Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.

Authors:  Mirjana Kovac; Gorana Mitic; Zeljko Mikovic; Nebojsa Antonijevic; Valentina Djordjevic; Danijela Mikovic; Vesna Mandic; Ljiljana Rakicevic; Dragica Radojkovic
Journal:  Clin Appl Thromb Hemost       Date:  2008-09-15       Impact factor: 2.389

Review 5.  Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered.

Authors:  J M Diaz; J S Schiffman; E S Urban; M Maccario
Journal:  Acta Neurol Scand       Date:  1992-10       Impact factor: 3.209

6.  The management of thrombosis in the antiphospholipid-antibody syndrome.

Authors:  M A Khamashta; M J Cuadrado; F Mujic; N A Taub; B J Hunt; G R Hughes
Journal:  N Engl J Med       Date:  1995-04-13       Impact factor: 91.245

  6 in total
  1 in total

1.  Simultaneous Multiple Thromboembolic Events in a Postpartum Patient.

Authors:  Ibtisam Ghashimi; Linda Jafarah; Amal Bakhsh; Ahmed Azzazy; Ahmed Royashed; Awad Awad; Ahmed Ramadan; Ghofran Hashimi; Refah Alqahtani; Abdullah Bakhsh
Journal:  Clin Pract Cases Emerg Med       Date:  2018-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.